Literature DB >> 21567456

FMR1 gray-zone alleles: association with Parkinson's disease in women?

Deborah A Hall1, Elizabeth Berry-Kravis, Wenting Zhang, Flora Tassone, Elaine Spector, Gary Zerbe, Paul J Hagerman, Bichun Ouyang, Maureen A Leehey.   

Abstract

Carriers of fragile X mental retardation 1 repeat expansions in the premutation range (55-200 CGG repeats), especially males, often develop tremor, ataxia, and parkinsonism. These neurological signs are believed to be a result of elevated levels of expanded CGG-repeat fragile X mental retardation 1 mRNA. The purpose of this study was to determine the prevalence of fragile X mental retardation 1 repeat expansions in a movement disorder population comprising subjects with all types of tremor, ataxia, and parkinsonism. We screened 335 consecutive patients with tremor, ataxia, or parkinsonism and 273 controls confirmed to have no movement disorders. There was no difference in fragile X mental retardation 1 premutation size expansions in the cases compared with controls. Eleven percent of the women with Parkinson's disease had fragile X mental retardation 1 gray-zone expansions compared with 4.4% of female controls (odds ratio of 3.2; 95% confidence interval, 1.2-8.7). Gray-zone expansions in patients with other phenotypes were not overrepresented in comparison with controls. Fragile X mental retardation 1 premutation range expansions are not more common in a mixed movement disorder population compared with controls. Our results, however, suggest that fragile X mental retardation 1 gray-zone alleles may be associated with Parkinson's disease in women.
Copyright © 2011 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21567456      PMCID: PMC3934001          DOI: 10.1002/mds.23755

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  43 in total

1.  Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation.

Authors:  B Bodega; S Bione; L Dalprà; D Toniolo; F Ornaghi; W Vegetti; E Ginelli; Anna Marozzi
Journal:  Hum Reprod       Date:  2005-12-16       Impact factor: 6.918

2.  Clinical involvement and protein expression in individuals with the FMR1 premutation.

Authors:  F Tassone; R J Hagerman; A K Taylor; J B Mills; S W Harris; L W Gane; P J Hagerman
Journal:  Am J Med Genet       Date:  2000-03-13

3.  Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: an exploratory case-control study.

Authors:  M D Benedetti; D M Maraganore; J H Bower; S K McDonnell; B J Peterson; J E Ahlskog; D J Schaid; W A Rocca
Journal:  Mov Disord       Date:  2001-09       Impact factor: 10.338

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

Review 5.  Implications for estrogens in Parkinson's disease: an epidemiological approach.

Authors:  Paolo Ragonese; Marco D'Amelio; Giovanni Savettieri
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

6.  Association of FMR1 repeat size with ovarian dysfunction.

Authors:  A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman
Journal:  Hum Reprod       Date:  2004-12-17       Impact factor: 6.918

7.  A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.

Authors:  S Siesling; A H Zwinderman; J P van Vugt; K Kieburtz; R A Roos
Journal:  Mov Disord       Date:  1997-03       Impact factor: 10.338

8.  Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.

Authors:  H Toledano-Alhadef; L Basel-Vanagaite; N Magal; B Davidov; S Ehrlich; V Drasinover; E Taub; G J Halpern; N Ginott; M Shohat
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

9.  Fragile X carrier screening and FMR1 allele distribution in the Japanese population.

Authors:  Susumu Otsuka; Yumiko Sakamoto; Haruhiko Siomi; Mituo Itakura; Kenji Yamamoto; Hideo Matumoto; Tsukasa Sasaki; Nobumasa Kato; Eiji Nanba
Journal:  Brain Dev       Date:  2009-02-10       Impact factor: 1.961

Review 10.  Prevalence of FMR1 repeat expansions in movement disorders. A systematic review.

Authors:  D A Hall; R J Hagerman; P J Hagerman; S Jacquemont; M A Leehey
Journal:  Neuroepidemiology       Date:  2006-02-21       Impact factor: 3.282

View more
  25 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

2.  Prevalence of CGG expansions of the FMR1 gene in a US population-based sample.

Authors:  Marsha Mailick Seltzer; Mei Wang Baker; Jinkuk Hong; Matthew Maenner; Jan Greenberg; Daniel Mandel
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-05-22       Impact factor: 3.568

3.  Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females.

Authors:  Danuta Z Loesch; Flora Tassone; George D Mellick; Malcolm Horne; Justin P Rubio; Minh Q Bui; David Francis; Elsdon Storey
Journal:  Mov Disord       Date:  2018-07       Impact factor: 10.338

4.  Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited.

Authors:  Yu-Qiong Niu; Jin-Chen Yang; Deborah A Hall; Maureen A Leehey; Flora Tassone; John M Olichney; Randi J Hagerman; Lin Zhang
Journal:  Parkinsonism Relat Disord       Date:  2014-01-18       Impact factor: 4.891

Review 5.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

6.  FMR1 CGG expansions: prevalence and sex ratios.

Authors:  Matthew J Maenner; Mei W Baker; Karl W Broman; Jianan Tian; Janel K Barnes; Anne Atkins; Elizabeth McPherson; Jinkuk Hong; Murray H Brilliant; Marsha R Mailick
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-06-05       Impact factor: 3.568

7.  Identification of expanded alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) study.

Authors:  Flora Tassone; Nimrah S Choudhary; Federica Tassone; Blythe Durbin-Johnson; Robin Hansen; Irva Hertz-Picciotto; Isaac Pessah
Journal:  J Autism Dev Disord       Date:  2013-03

8.  Screening for intermediate CGG alleles of FMR1 gene in male Iranian patients with Parkinsonism.

Authors:  Atefeh Entezari; Mahmoud Shekari Khaniani; Tayyeb Bahrami; Sima Mansoori Derakhshan; Hossein Darvish
Journal:  Neurol Sci       Date:  2016-10-01       Impact factor: 3.307

Review 9.  Understanding the neuropsychiatric phenotype of fragile X-associated tremor ataxia syndrome: a systematic review.

Authors:  R C Birch; K M Cornish; D R Hocking; J N Trollor
Journal:  Neuropsychol Rev       Date:  2014-05-15       Impact factor: 7.444

10.  Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series.

Authors:  Sarah M Debrey; Maureen A Leehey; Olga Klepitskaya; Christopher M Filley; Raj C Shah; Benzi Kluger; Elizabeth Berry-Kravis; Elaine Spector; Flora Tassone; Deborah A Hall
Journal:  Cerebellum       Date:  2016-10       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.